logo-loader

Investors 'beginning to realise the potential' in OptiBiotix Health - CEO

Published: 08:12 17 Jul 2018 EDT

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI), discusses with Proactive's Andrew Scott the company's recent share price performance and outlines what he's hoping to achieve over the next 6-12 months.

''There really is a big opportunity in the microbiome space which is seen as one of the hottest areas of healthcare''

''While it's a big market, you've got to have the science to deliver and we've won some major awards at industry conferences both in 2017 and 2018 for our science''.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 34 minutes ago